Cimatron's shares are publicly traded on the NASDAQ exchange and the TASE under the symbol CIMT. For more information, please visit Cimatron's web site at: http://www.cimatron.com 

Safe Harbor Statement

This press release includes forward looking statements, within the meaning of the Private Securities Litigation Reform Act of 1995, which are subject to risk and uncertainties that could cause actual results to differ materially from those anticipated. Such statements may relate to Cimatron's plans, objectives and expected financial and operating results. The words "may," "could," "would," "will," "believe," "anticipate," "estimate," "expect," "intend," "plan," and similar expressions or variations thereof are intended to identify forward-looking statements. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond Cimatron's ability to control. The risks and uncertainties that may affect forward looking statements include, but are not limited to: currency fluctuations, global economic and political conditions, market demand for Cimatron products and services, long sales cycles, new product development, assimilating future acquisitions, maintaining relationships with customers and partners, and increased competition. For more details about the risks and uncertainties related to Cimatron's business, refer to Cimatron's filings with the Securities and Exchange Commission. Cimatron cannot assess the impact of or the extent to which any single factor or risk, or combination of them, may cause. Cimatron undertakes no obligation to publicly update or revise any forward looking statements, whether as a result of new information, future events or otherwise.

                                                   CIMATRON LIMITED
                                           CONSOLIDATED STATEMENTS OF INCOME
                                 (US Dollars in thousands, except for per share data)
 
                                         Three months ended          Twelve months ended
                                            December 31,                December 31,
                                         2011           2010         2011            2010
 
    Total revenue                      12,226         11,013       40,714          36,074
 
    Total cost of revenue               1,477          1,634        5,383           5,876
 
    Gross profit                       10,749          9,379       35,331          30,198
 
    Research and development expenses, 
    net                                 2,031          1,692        6,739           6,014
 
    Selling, general and administrative 
    expenses                            6,799          6,282       24,453          22,053
    Operating income                    1,919          1,405        4,139           2,131
 
    Financial income (expenses), net     (186)            43         (195)             97
 
    Taxes on income                      (339)          (401)      (1,327)           (657)
 
    Other                                   3              1           (6)             (6)
 
    Net income                          1,397          1,048        2,611           1,565
 
    Less: Net (income) loss 
    attributable to the
    noncontrolling interest                44             45           57              26
 
    Net income attributable to 
    Cimatron's shareholders           $ 1,441        $ 1,093      $ 2,668         $ 1,591
    Net income per share - 
    basic and diluted                  $ 0.15         $ 0.12       $ 0.29          $ 0.18
 
    Weighted average number of 
    shares outstanding
 
      Basic EPS (in thousands)          9,300          8,959        9,252           9,000
 
      Diluted EPS (in thousands)        9,315          8,983        9,292                9,000